Literature DB >> 16394039

Smoking habits, nicotine use, and congenital malformations.

María M Morales-Suárez-Varela1, Camilla Bille, Kaare Christensen, Jorn Olsen.   

Abstract

OBJECTIVE: We examined whether maternal smoking and use of nicotine substitutes during the first 12 weeks of pregnancy increased the prevalence of congenital malformations in general and of certain congenital malformations in particular.
METHODS: In the Danish National Birth Cohort (1997-2003) we identified 76,768 pregnancies (and their subsequent singleton births); 20,603 were exposed to tobacco smoking during the first 12 weeks of pregnancy. Birth outcomes were collected by linkage to the Central Population Register, the National Patients Register, and the National Birth Register. We identified congenital malformations from the Hospital Medical Birth Registry as they were recorded at birth or in the first year of follow-up.
RESULTS: Smoking mothers were younger, weighed less, consumed more alcohol, and had received less education. Children exposed to prenatal tobacco smoking had no increase in congenital malformations prevalence compared with the nonexposed children in both crude and adjusted analyses. Children born to nonsmokers, but who used nicotine substitutes, had a slightly increased relative congenital malformations prevalence ratio; relative prevalence rate ratio was 1.61 (95% confidence interval 1.01-2.58), which represents a 60% increased risk. When the analysis was restricted to musculoskeletal malformations, the relative prevalence rate ratio was 2.63 (95% confidence interval 1.53-4.52).
CONCLUSION: Our results showed no increase in congenital malformations related to prenatal tobacco smoking. However, we identified an increase of malformations risk in nonsmokers using nicotine substitutes. This finding needs to be replicated in other data sources. LEVEL OF EVIDENCE: II-2.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16394039     DOI: 10.1097/01.AOG.0000194079.66834.d5

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  35 in total

Review 1.  Recommendations for the use of pharmacological smoking cessation strategies in pregnant women.

Authors:  Tim Coleman
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

2.  The use of central nervous system active drugs during pregnancy.

Authors:  Bengt Källén; Natalia Borg; Margareta Reis
Journal:  Pharmaceuticals (Basel)       Date:  2013-10-10

Review 3.  What do we know about the role of pharmacotherapy for smoking cessation before or during pregnancy?

Authors:  Cheryl A Oncken; H R Kranzler
Journal:  Nicotine Tob Res       Date:  2009-08-28       Impact factor: 4.244

4.  Role of transporter-mediated efflux in the placental biodisposition of bupropion and its metabolite, OH-bupropion.

Authors:  Sarah J Hemauer; Svetlana L Patrikeeva; Xiaoming Wang; Doaa R Abdelrahman; Gary D V Hankins; Mahmoud S Ahmed; Tatiana N Nanovskaya
Journal:  Biochem Pharmacol       Date:  2010-06-23       Impact factor: 5.858

Review 5.  [The Fetal Tobacco Syndrome - A statement of the Austrian Societies for General- and Family Medicine (ÖGAM), Gynecology and Obstetrics (ÖGGG), Hygiene, Microbiology and Preventive Medicine (ÖGHMP), Pediatrics and Adolescence Medicine (ÖGKJ) as well as Pneumology (ÖGP)].

Authors:  Fritz Horak; Tamas Fazekas; Angela Zacharasiewicz; Ernst Eber; Herbert Kiss; Alfred Lichtenschopf; Manfred Neuberger; Rudolf Schmitzberger; Burkhard Simma; Andree Wilhelm-Mitteräcker; Josef Riedler
Journal:  Wien Klin Wochenschr       Date:  2011-12-22       Impact factor: 1.704

Review 6.  Maternal smoking during pregnancy and child outcomes: real or spurious effect?

Authors:  Valerie S Knopik
Journal:  Dev Neuropsychol       Date:  2009       Impact factor: 2.253

7.  Maternal Smoking During Pregnancy and Offspring Birth Weight: A Genetically-Informed Approach Comparing Multiple Raters.

Authors:  Valerie S Knopik; Kristine Marceau; Rohan H C Palmer; Taylor F Smith; Andrew C Heath
Journal:  Behav Genet       Date:  2015-10-22       Impact factor: 2.805

Review 8.  Long-term consequences of fetal and neonatal nicotine exposure: a critical review.

Authors:  Jennifer E Bruin; Hertzel C Gerstein; Alison C Holloway
Journal:  Toxicol Sci       Date:  2010-04-02       Impact factor: 4.849

9.  Missouri Mothers and Their Children: A Family Study of the Effects of Genetics and the Prenatal Environment.

Authors:  Valerie S Knopik; Andrew C Heath; Kristine Marceau; Rohan H C Palmer; John E McGeary; Alexandre Todorov; Allison Schettini Evans
Journal:  Twin Res Hum Genet       Date:  2015-07-29       Impact factor: 1.587

10.  Early Life Exposure to Nicotine: Postnatal Metabolic, Neurobehavioral and Respiratory Outcomes and the Development of Childhood Cancers.

Authors:  Laiba Jamshed; Genevieve A Perono; Shanza Jamshed; Alison C Holloway
Journal:  Toxicol Sci       Date:  2020-11-01       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.